News | August 11, 2008

FDA Clears Infrared Thermal Imaging Camera

August 12, 2008 - American HealthChoice Inc. (AMHI), a medical services company with medical clinics in Texas and Tennessee, said today the FDA approved its OmniBody Scan, an infrared thermal imaging camera that will be able to detect patterns of abnormality within the human body.

In conjunction with existing technologies, the OmniBody Scan will be able to identify problems early enough for prevention and treatment, according to the company.

"Our initial focus will be the worldwide problem of breast cancer,” said Pat McGlashan, president of RehabCo, a division of AMHI. “The dilemma that all women have is that having X-rays to detect breast cancer may cause breast cancer. The OmniBody Scan is a noninvasive tool that will have no harmful side effects. The earlier that breast cancer is detected equates to a much higher chance of survival, especially with Inflammatory Breast Cancer.”

The OmniBody Scan is manufactured specifically for American HealthChoice by an infrared imaging manufacturer. Efforts have begun to solicit resellers to penetrate the U.S. market with both the OmniBody Scan and the company's adjunct support system of providing high quality interpretations of the infrared images, said AMHI.

Five years ago, the U.S. Preventive Services Task Force, an independent panel of experts in primary care and prevention, examined data from numerous clinical trials and estimated that screening mammography every one or two years in women in their 40s resulted in a 15 percent decrease in breast cancer mortality after 14 years of follow-up. But, analyses also made note of the potential harm of screening, including radiation exposure, procedure- associated pain, false-positive results, over-diagnosis and potentially unnecessary treatment.

The OmniBody Scan, a noninvasive technology reportedly with no side effects, is available immediately.

For more information: www.americanhealthchoice.com, www.omnibodyscan.com

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init